|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:SPINT2-TYROBP (FusionGDB2 ID:85266) |
Fusion Gene Summary for SPINT2-TYROBP |
Fusion gene summary |
Fusion gene information | Fusion gene name: SPINT2-TYROBP | Fusion gene ID: 85266 | Hgene | Tgene | Gene symbol | SPINT2 | TYROBP | Gene ID | 10653 | 7305 |
Gene name | serine peptidase inhibitor, Kunitz type 2 | transmembrane immune signaling adaptor TYROBP | |
Synonyms | DIAR3|HAI-2|HAI2|Kop|PB | DAP12|KARAP|PLOSL|PLOSL1 | |
Cytomap | 19q13.2 | 19q13.12 | |
Type of gene | protein-coding | protein-coding | |
Description | kunitz-type protease inhibitor 2hepatocyte growth factor activator inhibitor type 2serine protease inhibitor, Kunitz type, 2testicular tissue protein Li 183 | TYRO protein tyrosine kinase-binding proteinDNAX adaptor protein 12DNAX-activation protein 12KAR-associated proteinTYRO protein tyrosine kinase binding proteinkiller-activating receptor-associated proteinpolycystic lipomembranous osteodysplasia with | |
Modification date | 20200315 | 20200329 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000301244, ENST00000587090, ENST00000454580, | ENST00000424586, ENST00000585901, ENST00000544690, ENST00000262629, ENST00000589517, | |
Fusion gene scores | * DoF score | 16 X 8 X 9=1152 | 5 X 6 X 4=120 |
# samples | 21 | 7 | |
** MAII score | log2(21/1152*10)=-2.45567948377619 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(7/120*10)=-0.777607578663552 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: SPINT2 [Title/Abstract] AND TYROBP [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | SPINT2(38755638)-TYROBP(36398482), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | SPINT2 | GO:0022408 | negative regulation of cell-cell adhesion | 19592578 |
Hgene | SPINT2 | GO:2000146 | negative regulation of cell motility | 19592578 |
Tgene | TYROBP | GO:0002274 | myeloid leukocyte activation | 10604985 |
Tgene | TYROBP | GO:0050821 | protein stabilization | 25957402 |
Fusion gene breakpoints across SPINT2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across TYROBP (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | OV | TCGA-57-1994-01A | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - |
ChimerDB4 | OV | TCGA-57-1994 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399211 | - |
ChimerDB4 | OV | TCGA-57-1994-01A | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399209 | - |
ChimerDB4 | OV | TCGA-57-1994-01A | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - |
Top |
Fusion Gene ORF analysis for SPINT2-TYROBP |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000301244 | ENST00000424586 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - |
In-frame | ENST00000301244 | ENST00000585901 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - |
In-frame | ENST00000301244 | ENST00000544690 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - |
In-frame | ENST00000301244 | ENST00000262629 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - |
In-frame | ENST00000301244 | ENST00000589517 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - |
intron-3CDS | ENST00000587090 | ENST00000424586 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - |
intron-3CDS | ENST00000587090 | ENST00000585901 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - |
intron-3CDS | ENST00000587090 | ENST00000544690 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - |
intron-3CDS | ENST00000587090 | ENST00000262629 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - |
intron-3CDS | ENST00000587090 | ENST00000589517 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - |
In-frame | ENST00000454580 | ENST00000424586 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - |
In-frame | ENST00000454580 | ENST00000585901 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - |
In-frame | ENST00000454580 | ENST00000544690 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - |
In-frame | ENST00000454580 | ENST00000262629 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - |
In-frame | ENST00000454580 | ENST00000589517 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - |
5CDS-intron | ENST00000301244 | ENST00000424586 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399211 | - |
5CDS-intron | ENST00000301244 | ENST00000585901 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399211 | - |
5CDS-intron | ENST00000301244 | ENST00000544690 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399211 | - |
5CDS-intron | ENST00000301244 | ENST00000262629 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399211 | - |
5CDS-intron | ENST00000301244 | ENST00000589517 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399211 | - |
intron-intron | ENST00000587090 | ENST00000424586 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399211 | - |
intron-intron | ENST00000587090 | ENST00000585901 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399211 | - |
intron-intron | ENST00000587090 | ENST00000544690 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399211 | - |
intron-intron | ENST00000587090 | ENST00000262629 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399211 | - |
intron-intron | ENST00000587090 | ENST00000589517 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399211 | - |
5CDS-intron | ENST00000454580 | ENST00000424586 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399211 | - |
5CDS-intron | ENST00000454580 | ENST00000585901 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399211 | - |
5CDS-intron | ENST00000454580 | ENST00000544690 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399211 | - |
5CDS-intron | ENST00000454580 | ENST00000262629 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399211 | - |
5CDS-intron | ENST00000454580 | ENST00000589517 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399211 | - |
5CDS-intron | ENST00000301244 | ENST00000424586 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399209 | - |
5CDS-intron | ENST00000301244 | ENST00000585901 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399209 | - |
5CDS-intron | ENST00000301244 | ENST00000544690 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399209 | - |
5CDS-intron | ENST00000301244 | ENST00000262629 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399209 | - |
5CDS-intron | ENST00000301244 | ENST00000589517 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399209 | - |
intron-intron | ENST00000587090 | ENST00000424586 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399209 | - |
intron-intron | ENST00000587090 | ENST00000585901 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399209 | - |
intron-intron | ENST00000587090 | ENST00000544690 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399209 | - |
intron-intron | ENST00000587090 | ENST00000262629 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399209 | - |
intron-intron | ENST00000587090 | ENST00000589517 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399209 | - |
5CDS-intron | ENST00000454580 | ENST00000424586 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399209 | - |
5CDS-intron | ENST00000454580 | ENST00000585901 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399209 | - |
5CDS-intron | ENST00000454580 | ENST00000544690 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399209 | - |
5CDS-intron | ENST00000454580 | ENST00000262629 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399209 | - |
5CDS-intron | ENST00000454580 | ENST00000589517 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36399209 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000301244 | SPINT2 | chr19 | 38755638 | + | ENST00000424586 | TYROBP | chr19 | 36398482 | - | 954 | 541 | 830 | 0 | 277 |
ENST00000301244 | SPINT2 | chr19 | 38755638 | + | ENST00000585901 | TYROBP | chr19 | 36398482 | - | 1048 | 541 | 411 | 881 | 156 |
ENST00000301244 | SPINT2 | chr19 | 38755638 | + | ENST00000544690 | TYROBP | chr19 | 36398482 | - | 955 | 541 | 833 | 0 | 278 |
ENST00000301244 | SPINT2 | chr19 | 38755638 | + | ENST00000262629 | TYROBP | chr19 | 36398482 | - | 948 | 541 | 833 | 0 | 278 |
ENST00000301244 | SPINT2 | chr19 | 38755638 | + | ENST00000589517 | TYROBP | chr19 | 36398482 | - | 795 | 541 | 767 | 0 | 256 |
ENST00000454580 | SPINT2 | chr19 | 38755638 | + | ENST00000424586 | TYROBP | chr19 | 36398482 | - | 836 | 423 | 712 | 2 | 237 |
ENST00000454580 | SPINT2 | chr19 | 38755638 | + | ENST00000585901 | TYROBP | chr19 | 36398482 | - | 930 | 423 | 293 | 763 | 156 |
ENST00000454580 | SPINT2 | chr19 | 38755638 | + | ENST00000544690 | TYROBP | chr19 | 36398482 | - | 837 | 423 | 715 | 2 | 238 |
ENST00000454580 | SPINT2 | chr19 | 38755638 | + | ENST00000262629 | TYROBP | chr19 | 36398482 | - | 830 | 423 | 715 | 2 | 238 |
ENST00000454580 | SPINT2 | chr19 | 38755638 | + | ENST00000589517 | TYROBP | chr19 | 36398482 | - | 677 | 423 | 649 | 2 | 216 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000301244 | ENST00000424586 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - | 0.11416173 | 0.8858382 |
ENST00000301244 | ENST00000585901 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - | 0.20831585 | 0.7916842 |
ENST00000301244 | ENST00000544690 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - | 0.09346838 | 0.9065317 |
ENST00000301244 | ENST00000262629 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - | 0.095333464 | 0.90466654 |
ENST00000301244 | ENST00000589517 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - | 0.081613526 | 0.91838646 |
ENST00000454580 | ENST00000424586 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - | 0.06179654 | 0.9382034 |
ENST00000454580 | ENST00000585901 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - | 0.15306745 | 0.8469326 |
ENST00000454580 | ENST00000544690 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - | 0.058851667 | 0.9411484 |
ENST00000454580 | ENST00000262629 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - | 0.0640796 | 0.9359204 |
ENST00000454580 | ENST00000589517 | SPINT2 | chr19 | 38755638 | + | TYROBP | chr19 | 36398482 | - | 0.0430909 | 0.9569091 |
Top |
Fusion Genomic Features for SPINT2-TYROBP |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for SPINT2-TYROBP |
Go to FGviewer for the breakpoints of chr19:38755638-chr19:36398482 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | TYROBP | chr19:38755638 | chr19:36398482 | ENST00000262629 | 1 | 5 | 80_108 | 31.333333333333332 | 114.0 | Domain | Note=ITAM | |
Tgene | TYROBP | chr19:38755638 | chr19:36398482 | ENST00000544690 | 0 | 4 | 80_108 | 20.333333333333332 | 103.0 | Domain | Note=ITAM | |
Tgene | TYROBP | chr19:38755638 | chr19:36398482 | ENST00000589517 | 1 | 5 | 80_108 | 31.333333333333332 | 113.0 | Domain | Note=ITAM | |
Tgene | TYROBP | chr19:38755638 | chr19:36398482 | ENST00000262629 | 1 | 5 | 62_113 | 31.333333333333332 | 114.0 | Topological domain | Cytoplasmic | |
Tgene | TYROBP | chr19:38755638 | chr19:36398482 | ENST00000544690 | 0 | 4 | 22_40 | 20.333333333333332 | 103.0 | Topological domain | Extracellular | |
Tgene | TYROBP | chr19:38755638 | chr19:36398482 | ENST00000544690 | 0 | 4 | 62_113 | 20.333333333333332 | 103.0 | Topological domain | Cytoplasmic | |
Tgene | TYROBP | chr19:38755638 | chr19:36398482 | ENST00000589517 | 1 | 5 | 62_113 | 31.333333333333332 | 113.0 | Topological domain | Cytoplasmic | |
Tgene | TYROBP | chr19:38755638 | chr19:36398482 | ENST00000262629 | 1 | 5 | 41_61 | 31.333333333333332 | 114.0 | Transmembrane | Helical | |
Tgene | TYROBP | chr19:38755638 | chr19:36398482 | ENST00000544690 | 0 | 4 | 41_61 | 20.333333333333332 | 103.0 | Transmembrane | Helical | |
Tgene | TYROBP | chr19:38755638 | chr19:36398482 | ENST00000589517 | 1 | 5 | 41_61 | 31.333333333333332 | 113.0 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | SPINT2 | chr19:38755638 | chr19:36398482 | ENST00000301244 | + | 1 | 7 | 219_252 | 35.333333333333336 | 253.0 | Topological domain | Cytoplasmic |
Hgene | SPINT2 | chr19:38755638 | chr19:36398482 | ENST00000301244 | + | 1 | 7 | 28_197 | 35.333333333333336 | 253.0 | Topological domain | Extracellular |
Hgene | SPINT2 | chr19:38755638 | chr19:36398482 | ENST00000454580 | + | 1 | 6 | 219_252 | 35.333333333333336 | 196.0 | Topological domain | Cytoplasmic |
Hgene | SPINT2 | chr19:38755638 | chr19:36398482 | ENST00000454580 | + | 1 | 6 | 28_197 | 35.333333333333336 | 196.0 | Topological domain | Extracellular |
Hgene | SPINT2 | chr19:38755638 | chr19:36398482 | ENST00000301244 | + | 1 | 7 | 198_218 | 35.333333333333336 | 253.0 | Transmembrane | Helical |
Hgene | SPINT2 | chr19:38755638 | chr19:36398482 | ENST00000454580 | + | 1 | 6 | 198_218 | 35.333333333333336 | 196.0 | Transmembrane | Helical |
Tgene | TYROBP | chr19:38755638 | chr19:36398482 | ENST00000262629 | 1 | 5 | 22_40 | 31.333333333333332 | 114.0 | Topological domain | Extracellular | |
Tgene | TYROBP | chr19:38755638 | chr19:36398482 | ENST00000589517 | 1 | 5 | 22_40 | 31.333333333333332 | 113.0 | Topological domain | Extracellular |
Top |
Fusion Gene Sequence for SPINT2-TYROBP |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000301244_ENST00000424586_TCGA-57-1994-01A_SPINT2_chr19_38755638_+_TYROBP_chr19_36398482_length(transcript)=954nt_BP=541nt GCGGCCGCGCAGGTGCCTGCCCTTTGCGCCTGCGCCCAGCTCGCCCTGCCTAGCCAGGTGCGCCCCGCCCCCTGCCTGCCCGGCCACCTT CGGGAGCCGCTTCCAATAGGCGTTCGCCATTGGCTCTGGCGACCTCCGCGCGTTGGGAGGTGTAGCGCGGCTCTGAACGCGCTGAGGGCC GTTGAGTGTCGCAGGCGGCGAGGGCGCGAGTGAGGAGCAGACCCAGGCATCGCGCGCCGAGAAGGCCGGGCGTCCCCACACTGAAGGTCC GGAAAGGCGACTTCCGGGGGCTTTGGCACCTGGCGGACCCTCCCGGAGCGTCGGCACCTGAACGCGAGGCGCTCCATTGCGCGTGCGCGT TGAGGGGCTTCCCGCACCTGATCGCGAGACCCCAACGGCTGGTGGCGTCGCCTGCGCGTCTCGGCTGAGCTGGCCATGGCGCAGCTGTGC GGGCTGAGGCGGAGCCGGGCGTTTCTCGCCCTGCTGGGATCGCTGCTCCTCTCTGGGGTCCTGGCGGCCGACCGAGAACGCAGCATCCAC GATTGCAGTTGCTCTACGGTGAGCCCGGGCGTGCTGGCAGGGATCGTGATGGGAGACCTGGTGCTGACAGTGCTCATTGCCCTGGCCGTG TACTTCCTGGGCCGGCTGGTCCCTCGGGGGCGAGGGGCTGCGGAGGCGACCCGGAAACAGCGTATCACTGAGACCGAGTCGCCTTATCAG GAGCTCCAGGGTCAGAGGTCGGATGTCTACAGCGACCTCAACACACAGAGGCCGTATTACAAATGAGCCCGAATCATGACAGTCAGCAAC ATGATACCTGGATCCAGCCATTCCTGAAGCCCACCCTGCACCTCATTCCAACTCCTACCGCGATACAGACCCACAGAGTGCCATCCCTGA >In-frame_ENST00000301244_ENST00000424586_TCGA-57-1994-01A_SPINT2_chr19_38755638_+_TYROBP_chr19_36398482_length(amino acids)=277AA_start in transcript=830_stop in transcript=0 MAGSRYHVADCHDSGSFVIRPLCVEVAVDIRPLTLELLIRRLGLSDTLFPGRLRSPSPPRDQPAQEVHGQGNEHCQHQVSHHDPCQHARA HRRATAIVDAAFSVGRQDPREEQRSQQGEKRPAPPQPAQLRHGQLSRDAQATPPAVGVSRSGAGSPSTRTRNGAPRVQVPTLREGPPGAK APGSRLSGPSVWGRPAFSARDAWVCSSLAPSPPATLNGPQRVQSRATPPNARRSPEPMANAYWKRLPKVAGQAGGGAHLARQGELGAGAK -------------------------------------------------------------- >In-frame_ENST00000301244_ENST00000585901_TCGA-57-1994-01A_SPINT2_chr19_38755638_+_TYROBP_chr19_36398482_length(transcript)=1048nt_BP=541nt GCGGCCGCGCAGGTGCCTGCCCTTTGCGCCTGCGCCCAGCTCGCCCTGCCTAGCCAGGTGCGCCCCGCCCCCTGCCTGCCCGGCCACCTT CGGGAGCCGCTTCCAATAGGCGTTCGCCATTGGCTCTGGCGACCTCCGCGCGTTGGGAGGTGTAGCGCGGCTCTGAACGCGCTGAGGGCC GTTGAGTGTCGCAGGCGGCGAGGGCGCGAGTGAGGAGCAGACCCAGGCATCGCGCGCCGAGAAGGCCGGGCGTCCCCACACTGAAGGTCC GGAAAGGCGACTTCCGGGGGCTTTGGCACCTGGCGGACCCTCCCGGAGCGTCGGCACCTGAACGCGAGGCGCTCCATTGCGCGTGCGCGT TGAGGGGCTTCCCGCACCTGATCGCGAGACCCCAACGGCTGGTGGCGTCGCCTGCGCGTCTCGGCTGAGCTGGCCATGGCGCAGCTGTGC GGGCTGAGGCGGAGCCGGGCGTTTCTCGCCCTGCTGGGATCGCTGCTCCTCTCTGGGGTCCTGGCGGCCGACCGAGAACGCAGCATCCAC GATTGCAGTTGCTCTACGGTGAGCCCGGGCGTGCTGGCAGGGATCGTGATGGGAGACCTGGTGCTGACAGTGCTCATTGCCCTGGCCGTG TACTTCCTGGGCCGGCTGGTCCCTCGGGGGCGAGGGGCTGCGGAGGGGATGGTAATGGAGGTGCTGATTTGGAATGACAAAACACCCTCA ACTCACCACTCTGCCTGTCTCTGCACCCCACAACACCCCTCACCTCCAGCAGCGACCCGGAAACAGCGTATCACTGAGACCGAGTCGCCT TATCAGGAGCTCCAGGGTCAGAGGTCGGATGTCTACAGCGACCTCAACACACAGAGGCCGTATTACAAATGAGCCCGAATCATGACAGTC AGCAACATGATACCTGGATCCAGCCATTCCTGAAGCCCACCCTGCACCTCATTCCAACTCCTACCGCGATACAGACCCACAGAGTGCCAT >In-frame_ENST00000301244_ENST00000585901_TCGA-57-1994-01A_SPINT2_chr19_38755638_+_TYROBP_chr19_36398482_length(amino acids)=156AA_start in transcript=411_stop in transcript=881 MRVSAELAMAQLCGLRRSRAFLALLGSLLLSGVLAADRERSIHDCSCSTVSPGVLAGIVMGDLVLTVLIALAVYFLGRLVPRGRGAAEGM -------------------------------------------------------------- >In-frame_ENST00000301244_ENST00000544690_TCGA-57-1994-01A_SPINT2_chr19_38755638_+_TYROBP_chr19_36398482_length(transcript)=955nt_BP=541nt GCGGCCGCGCAGGTGCCTGCCCTTTGCGCCTGCGCCCAGCTCGCCCTGCCTAGCCAGGTGCGCCCCGCCCCCTGCCTGCCCGGCCACCTT CGGGAGCCGCTTCCAATAGGCGTTCGCCATTGGCTCTGGCGACCTCCGCGCGTTGGGAGGTGTAGCGCGGCTCTGAACGCGCTGAGGGCC GTTGAGTGTCGCAGGCGGCGAGGGCGCGAGTGAGGAGCAGACCCAGGCATCGCGCGCCGAGAAGGCCGGGCGTCCCCACACTGAAGGTCC GGAAAGGCGACTTCCGGGGGCTTTGGCACCTGGCGGACCCTCCCGGAGCGTCGGCACCTGAACGCGAGGCGCTCCATTGCGCGTGCGCGT TGAGGGGCTTCCCGCACCTGATCGCGAGACCCCAACGGCTGGTGGCGTCGCCTGCGCGTCTCGGCTGAGCTGGCCATGGCGCAGCTGTGC GGGCTGAGGCGGAGCCGGGCGTTTCTCGCCCTGCTGGGATCGCTGCTCCTCTCTGGGGTCCTGGCGGCCGACCGAGAACGCAGCATCCAC GATTGCAGTTGCTCTACGGTGAGCCCGGGCGTGCTGGCAGGGATCGTGATGGGAGACCTGGTGCTGACAGTGCTCATTGCCCTGGCCGTG TACTTCCTGGGCCGGCTGGTCCCTCGGGGGCGAGGGGCTGCGGAGGCAGCGACCCGGAAACAGCGTATCACTGAGACCGAGTCGCCTTAT CAGGAGCTCCAGGGTCAGAGGTCGGATGTCTACAGCGACCTCAACACACAGAGGCCGTATTACAAATGAGCCCGAATCATGACAGTCAGC AACATGATACCTGGATCCAGCCATTCCTGAAGCCCACCCTGCACCTCATTCCAACTCCTACCGCGATACAGACCCACAGAGTGCCATCCC >In-frame_ENST00000301244_ENST00000544690_TCGA-57-1994-01A_SPINT2_chr19_38755638_+_TYROBP_chr19_36398482_length(amino acids)=278AA_start in transcript=833_stop in transcript=0 MAGSRYHVADCHDSGSFVIRPLCVEVAVDIRPLTLELLIRRLGLSDTLFPGRCLRSPSPPRDQPAQEVHGQGNEHCQHQVSHHDPCQHAR AHRRATAIVDAAFSVGRQDPREEQRSQQGEKRPAPPQPAQLRHGQLSRDAQATPPAVGVSRSGAGSPSTRTRNGAPRVQVPTLREGPPGA KAPGSRLSGPSVWGRPAFSARDAWVCSSLAPSPPATLNGPQRVQSRATPPNARRSPEPMANAYWKRLPKVAGQAGGGAHLARQGELGAGA -------------------------------------------------------------- >In-frame_ENST00000301244_ENST00000262629_TCGA-57-1994-01A_SPINT2_chr19_38755638_+_TYROBP_chr19_36398482_length(transcript)=948nt_BP=541nt GCGGCCGCGCAGGTGCCTGCCCTTTGCGCCTGCGCCCAGCTCGCCCTGCCTAGCCAGGTGCGCCCCGCCCCCTGCCTGCCCGGCCACCTT CGGGAGCCGCTTCCAATAGGCGTTCGCCATTGGCTCTGGCGACCTCCGCGCGTTGGGAGGTGTAGCGCGGCTCTGAACGCGCTGAGGGCC GTTGAGTGTCGCAGGCGGCGAGGGCGCGAGTGAGGAGCAGACCCAGGCATCGCGCGCCGAGAAGGCCGGGCGTCCCCACACTGAAGGTCC GGAAAGGCGACTTCCGGGGGCTTTGGCACCTGGCGGACCCTCCCGGAGCGTCGGCACCTGAACGCGAGGCGCTCCATTGCGCGTGCGCGT TGAGGGGCTTCCCGCACCTGATCGCGAGACCCCAACGGCTGGTGGCGTCGCCTGCGCGTCTCGGCTGAGCTGGCCATGGCGCAGCTGTGC GGGCTGAGGCGGAGCCGGGCGTTTCTCGCCCTGCTGGGATCGCTGCTCCTCTCTGGGGTCCTGGCGGCCGACCGAGAACGCAGCATCCAC GATTGCAGTTGCTCTACGGTGAGCCCGGGCGTGCTGGCAGGGATCGTGATGGGAGACCTGGTGCTGACAGTGCTCATTGCCCTGGCCGTG TACTTCCTGGGCCGGCTGGTCCCTCGGGGGCGAGGGGCTGCGGAGGCAGCGACCCGGAAACAGCGTATCACTGAGACCGAGTCGCCTTAT CAGGAGCTCCAGGGTCAGAGGTCGGATGTCTACAGCGACCTCAACACACAGAGGCCGTATTACAAATGAGCCCGAATCATGACAGTCAGC AACATGATACCTGGATCCAGCCATTCCTGAAGCCCACCCTGCACCTCATTCCAACTCCTACCGCGATACAGACCCACAGAGTGCCATCCC >In-frame_ENST00000301244_ENST00000262629_TCGA-57-1994-01A_SPINT2_chr19_38755638_+_TYROBP_chr19_36398482_length(amino acids)=278AA_start in transcript=833_stop in transcript=0 MAGSRYHVADCHDSGSFVIRPLCVEVAVDIRPLTLELLIRRLGLSDTLFPGRCLRSPSPPRDQPAQEVHGQGNEHCQHQVSHHDPCQHAR AHRRATAIVDAAFSVGRQDPREEQRSQQGEKRPAPPQPAQLRHGQLSRDAQATPPAVGVSRSGAGSPSTRTRNGAPRVQVPTLREGPPGA KAPGSRLSGPSVWGRPAFSARDAWVCSSLAPSPPATLNGPQRVQSRATPPNARRSPEPMANAYWKRLPKVAGQAGGGAHLARQGELGAGA -------------------------------------------------------------- >In-frame_ENST00000301244_ENST00000589517_TCGA-57-1994-01A_SPINT2_chr19_38755638_+_TYROBP_chr19_36398482_length(transcript)=795nt_BP=541nt GCGGCCGCGCAGGTGCCTGCCCTTTGCGCCTGCGCCCAGCTCGCCCTGCCTAGCCAGGTGCGCCCCGCCCCCTGCCTGCCCGGCCACCTT CGGGAGCCGCTTCCAATAGGCGTTCGCCATTGGCTCTGGCGACCTCCGCGCGTTGGGAGGTGTAGCGCGGCTCTGAACGCGCTGAGGGCC GTTGAGTGTCGCAGGCGGCGAGGGCGCGAGTGAGGAGCAGACCCAGGCATCGCGCGCCGAGAAGGCCGGGCGTCCCCACACTGAAGGTCC GGAAAGGCGACTTCCGGGGGCTTTGGCACCTGGCGGACCCTCCCGGAGCGTCGGCACCTGAACGCGAGGCGCTCCATTGCGCGTGCGCGT TGAGGGGCTTCCCGCACCTGATCGCGAGACCCCAACGGCTGGTGGCGTCGCCTGCGCGTCTCGGCTGAGCTGGCCATGGCGCAGCTGTGC GGGCTGAGGCGGAGCCGGGCGTTTCTCGCCCTGCTGGGATCGCTGCTCCTCTCTGGGGTCCTGGCGGCCGACCGAGAACGCAGCATCCAC GATTGCAGTTGCTCTACGGTGAGCCCGGGCGTGCTGGCAGGGATCGTGATGGGAGACCTGGTGCTGACAGTGCTCATTGCCCTGGCCGTG TACTTCCTGGGCCGGCTGGTCCCTCGGGGGCGAGGGGCTGCGGAGGCGACCCGGAAACAGCGTATCACTGAGACCGAGTCGCCTTATCAG >In-frame_ENST00000301244_ENST00000589517_TCGA-57-1994-01A_SPINT2_chr19_38755638_+_TYROBP_chr19_36398482_length(amino acids)=256AA_start in transcript=767_stop in transcript=0 MCVEVAVDIRPLTLELLIRRLGLSDTLFPGRLRSPSPPRDQPAQEVHGQGNEHCQHQVSHHDPCQHARAHRRATAIVDAAFSVGRQDPRE EQRSQQGEKRPAPPQPAQLRHGQLSRDAQATPPAVGVSRSGAGSPSTRTRNGAPRVQVPTLREGPPGAKAPGSRLSGPSVWGRPAFSARD -------------------------------------------------------------- >In-frame_ENST00000454580_ENST00000424586_TCGA-57-1994-01A_SPINT2_chr19_38755638_+_TYROBP_chr19_36398482_length(transcript)=836nt_BP=423nt ATTGGCTCTGGCGACCTCCGCGCGTTGGGAGGTGTAGCGCGGCTCTGAACGCGCTGAGGGCCGTTGAGTGTCGCAGGCGGCGAGGGCGCG AGTGAGGAGCAGACCCAGGCATCGCGCGCCGAGAAGGCCGGGCGTCCCCACACTGAAGGTCCGGAAAGGCGACTTCCGGGGGCTTTGGCA CCTGGCGGACCCTCCCGGAGCGTCGGCACCTGAACGCGAGGCGCTCCATTGCGCGTGCGCGTTGAGGGGCTTCCCGCACCTGATCGCGAG ACCCCAACGGCTGGTGGCGTCGCCTGCGCGTCTCGGCTGAGCTGGCCATGGCGCAGCTGTGCGGGCTGAGGCGGAGCCGGGCGTTTCTCG CCCTGCTGGGATCGCTGCTCCTCTCTGGGGTCCTGGCGGCCGACCGAGAACGCAGCATCCACGATTGCAGTTGCTCTACGGTGAGCCCGG GCGTGCTGGCAGGGATCGTGATGGGAGACCTGGTGCTGACAGTGCTCATTGCCCTGGCCGTGTACTTCCTGGGCCGGCTGGTCCCTCGGG GGCGAGGGGCTGCGGAGGCGACCCGGAAACAGCGTATCACTGAGACCGAGTCGCCTTATCAGGAGCTCCAGGGTCAGAGGTCGGATGTCT ACAGCGACCTCAACACACAGAGGCCGTATTACAAATGAGCCCGAATCATGACAGTCAGCAACATGATACCTGGATCCAGCCATTCCTGAA GCCCACCCTGCACCTCATTCCAACTCCTACCGCGATACAGACCCACAGAGTGCCATCCCTGAGAGACCAGACCGCTCCCCAATACTCTCC >In-frame_ENST00000454580_ENST00000424586_TCGA-57-1994-01A_SPINT2_chr19_38755638_+_TYROBP_chr19_36398482_length(amino acids)=237AA_start in transcript=712_stop in transcript=2 MAGSRYHVADCHDSGSFVIRPLCVEVAVDIRPLTLELLIRRLGLSDTLFPGRLRSPSPPRDQPAQEVHGQGNEHCQHQVSHHDPCQHARA HRRATAIVDAAFSVGRQDPREEQRSQQGEKRPAPPQPAQLRHGQLSRDAQATPPAVGVSRSGAGSPSTRTRNGAPRVQVPTLREGPPGAK -------------------------------------------------------------- >In-frame_ENST00000454580_ENST00000585901_TCGA-57-1994-01A_SPINT2_chr19_38755638_+_TYROBP_chr19_36398482_length(transcript)=930nt_BP=423nt ATTGGCTCTGGCGACCTCCGCGCGTTGGGAGGTGTAGCGCGGCTCTGAACGCGCTGAGGGCCGTTGAGTGTCGCAGGCGGCGAGGGCGCG AGTGAGGAGCAGACCCAGGCATCGCGCGCCGAGAAGGCCGGGCGTCCCCACACTGAAGGTCCGGAAAGGCGACTTCCGGGGGCTTTGGCA CCTGGCGGACCCTCCCGGAGCGTCGGCACCTGAACGCGAGGCGCTCCATTGCGCGTGCGCGTTGAGGGGCTTCCCGCACCTGATCGCGAG ACCCCAACGGCTGGTGGCGTCGCCTGCGCGTCTCGGCTGAGCTGGCCATGGCGCAGCTGTGCGGGCTGAGGCGGAGCCGGGCGTTTCTCG CCCTGCTGGGATCGCTGCTCCTCTCTGGGGTCCTGGCGGCCGACCGAGAACGCAGCATCCACGATTGCAGTTGCTCTACGGTGAGCCCGG GCGTGCTGGCAGGGATCGTGATGGGAGACCTGGTGCTGACAGTGCTCATTGCCCTGGCCGTGTACTTCCTGGGCCGGCTGGTCCCTCGGG GGCGAGGGGCTGCGGAGGGGATGGTAATGGAGGTGCTGATTTGGAATGACAAAACACCCTCAACTCACCACTCTGCCTGTCTCTGCACCC CACAACACCCCTCACCTCCAGCAGCGACCCGGAAACAGCGTATCACTGAGACCGAGTCGCCTTATCAGGAGCTCCAGGGTCAGAGGTCGG ATGTCTACAGCGACCTCAACACACAGAGGCCGTATTACAAATGAGCCCGAATCATGACAGTCAGCAACATGATACCTGGATCCAGCCATT CCTGAAGCCCACCCTGCACCTCATTCCAACTCCTACCGCGATACAGACCCACAGAGTGCCATCCCTGAGAGACCAGACCGCTCCCCAATA >In-frame_ENST00000454580_ENST00000585901_TCGA-57-1994-01A_SPINT2_chr19_38755638_+_TYROBP_chr19_36398482_length(amino acids)=156AA_start in transcript=293_stop in transcript=763 MRVSAELAMAQLCGLRRSRAFLALLGSLLLSGVLAADRERSIHDCSCSTVSPGVLAGIVMGDLVLTVLIALAVYFLGRLVPRGRGAAEGM -------------------------------------------------------------- >In-frame_ENST00000454580_ENST00000544690_TCGA-57-1994-01A_SPINT2_chr19_38755638_+_TYROBP_chr19_36398482_length(transcript)=837nt_BP=423nt ATTGGCTCTGGCGACCTCCGCGCGTTGGGAGGTGTAGCGCGGCTCTGAACGCGCTGAGGGCCGTTGAGTGTCGCAGGCGGCGAGGGCGCG AGTGAGGAGCAGACCCAGGCATCGCGCGCCGAGAAGGCCGGGCGTCCCCACACTGAAGGTCCGGAAAGGCGACTTCCGGGGGCTTTGGCA CCTGGCGGACCCTCCCGGAGCGTCGGCACCTGAACGCGAGGCGCTCCATTGCGCGTGCGCGTTGAGGGGCTTCCCGCACCTGATCGCGAG ACCCCAACGGCTGGTGGCGTCGCCTGCGCGTCTCGGCTGAGCTGGCCATGGCGCAGCTGTGCGGGCTGAGGCGGAGCCGGGCGTTTCTCG CCCTGCTGGGATCGCTGCTCCTCTCTGGGGTCCTGGCGGCCGACCGAGAACGCAGCATCCACGATTGCAGTTGCTCTACGGTGAGCCCGG GCGTGCTGGCAGGGATCGTGATGGGAGACCTGGTGCTGACAGTGCTCATTGCCCTGGCCGTGTACTTCCTGGGCCGGCTGGTCCCTCGGG GGCGAGGGGCTGCGGAGGCAGCGACCCGGAAACAGCGTATCACTGAGACCGAGTCGCCTTATCAGGAGCTCCAGGGTCAGAGGTCGGATG TCTACAGCGACCTCAACACACAGAGGCCGTATTACAAATGAGCCCGAATCATGACAGTCAGCAACATGATACCTGGATCCAGCCATTCCT GAAGCCCACCCTGCACCTCATTCCAACTCCTACCGCGATACAGACCCACAGAGTGCCATCCCTGAGAGACCAGACCGCTCCCCAATACTC >In-frame_ENST00000454580_ENST00000544690_TCGA-57-1994-01A_SPINT2_chr19_38755638_+_TYROBP_chr19_36398482_length(amino acids)=238AA_start in transcript=715_stop in transcript=2 MAGSRYHVADCHDSGSFVIRPLCVEVAVDIRPLTLELLIRRLGLSDTLFPGRCLRSPSPPRDQPAQEVHGQGNEHCQHQVSHHDPCQHAR AHRRATAIVDAAFSVGRQDPREEQRSQQGEKRPAPPQPAQLRHGQLSRDAQATPPAVGVSRSGAGSPSTRTRNGAPRVQVPTLREGPPGA -------------------------------------------------------------- >In-frame_ENST00000454580_ENST00000262629_TCGA-57-1994-01A_SPINT2_chr19_38755638_+_TYROBP_chr19_36398482_length(transcript)=830nt_BP=423nt ATTGGCTCTGGCGACCTCCGCGCGTTGGGAGGTGTAGCGCGGCTCTGAACGCGCTGAGGGCCGTTGAGTGTCGCAGGCGGCGAGGGCGCG AGTGAGGAGCAGACCCAGGCATCGCGCGCCGAGAAGGCCGGGCGTCCCCACACTGAAGGTCCGGAAAGGCGACTTCCGGGGGCTTTGGCA CCTGGCGGACCCTCCCGGAGCGTCGGCACCTGAACGCGAGGCGCTCCATTGCGCGTGCGCGTTGAGGGGCTTCCCGCACCTGATCGCGAG ACCCCAACGGCTGGTGGCGTCGCCTGCGCGTCTCGGCTGAGCTGGCCATGGCGCAGCTGTGCGGGCTGAGGCGGAGCCGGGCGTTTCTCG CCCTGCTGGGATCGCTGCTCCTCTCTGGGGTCCTGGCGGCCGACCGAGAACGCAGCATCCACGATTGCAGTTGCTCTACGGTGAGCCCGG GCGTGCTGGCAGGGATCGTGATGGGAGACCTGGTGCTGACAGTGCTCATTGCCCTGGCCGTGTACTTCCTGGGCCGGCTGGTCCCTCGGG GGCGAGGGGCTGCGGAGGCAGCGACCCGGAAACAGCGTATCACTGAGACCGAGTCGCCTTATCAGGAGCTCCAGGGTCAGAGGTCGGATG TCTACAGCGACCTCAACACACAGAGGCCGTATTACAAATGAGCCCGAATCATGACAGTCAGCAACATGATACCTGGATCCAGCCATTCCT GAAGCCCACCCTGCACCTCATTCCAACTCCTACCGCGATACAGACCCACAGAGTGCCATCCCTGAGAGACCAGACCGCTCCCCAATACTC >In-frame_ENST00000454580_ENST00000262629_TCGA-57-1994-01A_SPINT2_chr19_38755638_+_TYROBP_chr19_36398482_length(amino acids)=238AA_start in transcript=715_stop in transcript=2 MAGSRYHVADCHDSGSFVIRPLCVEVAVDIRPLTLELLIRRLGLSDTLFPGRCLRSPSPPRDQPAQEVHGQGNEHCQHQVSHHDPCQHAR AHRRATAIVDAAFSVGRQDPREEQRSQQGEKRPAPPQPAQLRHGQLSRDAQATPPAVGVSRSGAGSPSTRTRNGAPRVQVPTLREGPPGA -------------------------------------------------------------- >In-frame_ENST00000454580_ENST00000589517_TCGA-57-1994-01A_SPINT2_chr19_38755638_+_TYROBP_chr19_36398482_length(transcript)=677nt_BP=423nt ATTGGCTCTGGCGACCTCCGCGCGTTGGGAGGTGTAGCGCGGCTCTGAACGCGCTGAGGGCCGTTGAGTGTCGCAGGCGGCGAGGGCGCG AGTGAGGAGCAGACCCAGGCATCGCGCGCCGAGAAGGCCGGGCGTCCCCACACTGAAGGTCCGGAAAGGCGACTTCCGGGGGCTTTGGCA CCTGGCGGACCCTCCCGGAGCGTCGGCACCTGAACGCGAGGCGCTCCATTGCGCGTGCGCGTTGAGGGGCTTCCCGCACCTGATCGCGAG ACCCCAACGGCTGGTGGCGTCGCCTGCGCGTCTCGGCTGAGCTGGCCATGGCGCAGCTGTGCGGGCTGAGGCGGAGCCGGGCGTTTCTCG CCCTGCTGGGATCGCTGCTCCTCTCTGGGGTCCTGGCGGCCGACCGAGAACGCAGCATCCACGATTGCAGTTGCTCTACGGTGAGCCCGG GCGTGCTGGCAGGGATCGTGATGGGAGACCTGGTGCTGACAGTGCTCATTGCCCTGGCCGTGTACTTCCTGGGCCGGCTGGTCCCTCGGG GGCGAGGGGCTGCGGAGGCGACCCGGAAACAGCGTATCACTGAGACCGAGTCGCCTTATCAGGAGCTCCAGGGTCAGAGGTCGGATGTCT >In-frame_ENST00000454580_ENST00000589517_TCGA-57-1994-01A_SPINT2_chr19_38755638_+_TYROBP_chr19_36398482_length(amino acids)=216AA_start in transcript=649_stop in transcript=2 MCVEVAVDIRPLTLELLIRRLGLSDTLFPGRLRSPSPPRDQPAQEVHGQGNEHCQHQVSHHDPCQHARAHRRATAIVDAAFSVGRQDPRE EQRSQQGEKRPAPPQPAQLRHGQLSRDAQATPPAVGVSRSGAGSPSTRTRNGAPRVQVPTLREGPPGAKAPGSRLSGPSVWGRPAFSARD -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for SPINT2-TYROBP |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for SPINT2-TYROBP |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for SPINT2-TYROBP |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | SPINT2 | C0267663 | Congenital secretory diarrhea, sodium type (disorder) | 3 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | SPINT2 | C0007097 | Carcinoma | 1 | CTD_human |
Hgene | SPINT2 | C0011999 | Diastematomyelia | 1 | CTD_human |
Hgene | SPINT2 | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
Hgene | SPINT2 | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
Hgene | SPINT2 | C0027794 | Neural Tube Defects | 1 | CTD_human |
Hgene | SPINT2 | C0027806 | Neurenteric Cyst | 1 | CTD_human |
Hgene | SPINT2 | C0032045 | Placenta Disorders | 1 | CTD_human |
Hgene | SPINT2 | C0080218 | Tethered Cord Syndrome | 1 | CTD_human |
Hgene | SPINT2 | C0152234 | Iniencephaly | 1 | CTD_human |
Hgene | SPINT2 | C0152426 | Craniorachischisis | 1 | CTD_human |
Hgene | SPINT2 | C0152427 | Polydactyly | 1 | GENOMICS_ENGLAND |
Hgene | SPINT2 | C0155299 | Coloboma of optic disc | 1 | GENOMICS_ENGLAND |
Hgene | SPINT2 | C0205696 | Anaplastic carcinoma | 1 | CTD_human |
Hgene | SPINT2 | C0205697 | Carcinoma, Spindle-Cell | 1 | CTD_human |
Hgene | SPINT2 | C0205698 | Undifferentiated carcinoma | 1 | CTD_human |
Hgene | SPINT2 | C0205699 | Carcinomatosis | 1 | CTD_human |
Hgene | SPINT2 | C0266453 | Exencephaly | 1 | CTD_human |
Hgene | SPINT2 | C0302246 | Hexadactyly | 1 | GENOMICS_ENGLAND |
Hgene | SPINT2 | C0344479 | Spinal Cord Myelodysplasia | 1 | CTD_human |
Hgene | SPINT2 | C0702169 | Acrania | 1 | CTD_human |
Hgene | SPINT2 | C1257925 | Mammary Carcinoma, Animal | 1 | CTD_human |
Hgene | SPINT2 | C4275062 | Intestinal epithelial dysplasia | 1 | GENOMICS_ENGLAND |
Tgene | TYROBP | C0497327 | Dementia | 2 | GENOMICS_ENGLAND |
Tgene | TYROBP | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Tgene | TYROBP | C0023895 | Liver diseases | 1 | CTD_human |
Tgene | TYROBP | C0086565 | Liver Dysfunction | 1 | CTD_human |
Tgene | TYROBP | C4721893 | POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 1 | 1 | GENOMICS_ENGLAND |